Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.
暂无分享,去创建一个
R. Atmar | Jie Zhu | P. Jeffery | K. Hattotuwa | V. Bandi | Y. Qiu | K. K. Guntupalli | K. Guntupalli
[1] Chemokines and their receptors in asthma and chronic obstructive pulmonary disease , 2003, Current opinion in pulmonary medicine.
[2] R. Strieter. Interleukin-8: a very important chemokine of the human airway epithelium. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[3] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[4] S. Storey,et al. Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts. , 2002, American journal of physiology. Cell physiology.
[5] R. Pauwels,et al. Global Initiative for Chronic Obstructive Lung Diseases (GOLD). , 2002, Pulmonary pharmacology & therapeutics.
[6] B. Beghé,et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. , 2002, American journal of respiratory and critical care medicine.
[7] W. Bailey,et al. Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.
[8] L. Fabbri,et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[9] M. Burdick,et al. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. , 2001, American journal of respiratory and critical care medicine.
[10] E. Mason,et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. , 2001, American journal of respiratory and critical care medicine.
[11] P. Jeffery. Remodeling in asthma and chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.
[12] T. Seemungal,et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[13] L. Fabbri,et al. Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. , 2001, American journal of respiratory and critical care medicine.
[14] C. Owen. Chemokine receptors in airway disease: which receptors to target? , 2001, Pulmonary pharmacology & therapeutics.
[15] L. Fabbri,et al. Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[16] K. Wright,et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[17] J. Wedzicha. Mechanisms of exacerbations. , 2001, Novartis Foundation symposium.
[18] P. Jeffery,et al. Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. , 2000, Chest.
[19] T. Seemungal,et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[20] P. Hiemstra,et al. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD , 2000, The Journal of pathology.
[21] M. Matthay,et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. , 2000, American journal of respiratory and critical care medicine.
[22] R. Stockley,et al. Inflammation--role of the neutrophil and the eosinophil. , 2000, Seminars in respiratory infections.
[23] A. Sousa,et al. Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. , 2000, The European respiratory journal.
[24] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[25] V. Peinado,et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[26] F. Saulnier,et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. , 1999, American journal of respiratory and critical care medicine.
[27] J. Zimmerman,et al. Respiratory tract viral infections in inner-city asthmatic adults. , 1998, Archives of internal medicine.
[28] L. Fabbri,et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.
[29] M. Iannettoni,et al. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. , 1998, The Journal of clinical investigation.
[30] F. Saulnier,et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. , 1998, American journal of respiratory and critical care medicine.
[31] P. Proost,et al. Interleukin-8 and other CXC chemokines , 1998 .
[32] D. Wilkinson. In situ hybridization: a practical approach , 1998 .
[33] J. Baier,et al. Induction of neutrophil chemoattractant cytokines by Mycoplasma hominis in alveolar type II cells , 1997 .
[34] S. Wenzel,et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. , 1997, American journal of respiratory and critical care medicine.
[35] G. Zimmerman,et al. Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signaling of PMN adhesion. , 1997, American journal of respiratory cell and molecular biology.
[36] B. Balbi,et al. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. , 1997, The European respiratory journal.
[37] P. Herdewijn,et al. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. , 1997, Biochemistry.
[38] P. Jeffery,et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.
[39] J. G. Douglas,et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.
[40] R. Strieter,et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[41] J. M. Cousin,et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.
[42] C. Gerard,et al. Receptor binding specificity and pulmonary gene expression of the neutrophil-activating peptide ENA-78. , 1996, American journal of respiratory cell and molecular biology.
[43] L. Fabbri,et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.
[44] A. Chuntharapai,et al. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. , 1995, Journal of immunology.
[45] M. Burdick,et al. Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. , 1995, The American journal of physiology.
[46] G. Cox,et al. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. , 1995, Journal of immunology.
[47] Kwang Woo Kim,et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.
[48] M. Burdick,et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. , 1995, The Journal of clinical investigation.
[49] L. Fabbri,et al. Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.
[50] T. Standiford,et al. Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. , 1993, Thorax.
[51] L. Fabbri,et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. , 1993, The American review of respiratory disease.
[52] W. Wood,et al. Characterization of two high affinity human interleukin-8 receptors. , 1992, The Journal of biological chemistry.
[53] R. Strieter,et al. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8 , 1991, The Journal of experimental medicine.